✦ LIBER ✦

A fatal case of phlegmonous colitis in chronic hepatitis C receiving combination interferon and ribavirin therapy

✍ Scribed by S. H. Pang; K. De Silva; J. Napoli; B. E. Jones

Book ID: 109003576
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 151 KB
Volume: 39
Category: Article
ISSN: 1444-0903
DOI: 10.1111/j.1445-5994.2009.01919.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of lactoferrin in patients with c

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin

✍ Masahiko Kaito; Motoh Iwasa; Naoki Fujita; Yoshinao Kobayashi; Yuji Kojima; Jiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a

Thyroid dysfunction in patients with chr

Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis

✍ Kwong-Ming Kee; Chuan-Mo Lee; Jing-Houng Wang; Hung-Da Tung; Chi-Sin Changchien; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Adequate timing of ribavirin reduction i

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 171 KB

The significance of interferon and ribav

The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan

✍ Naoki Hiramatsu; Akinori Kasahara; Fumihiko Nakanishi; Takashi Toyama; Masahiko 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB